-
[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
-
ChemBase ID:
4142
-
Molecular Formular:
C18H22O5S
-
Molecular Mass:
350.42928
-
Monoisotopic Mass:
350.1187948
-
SMILES and InChIs
SMILES:
S(=O)(=O)(Oc1cc2c([C@@H]3[C@H]([C@H]4[C@](CC3)(C(=O)CC4)C)CC2)cc1)O
Canonical SMILES:
O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
InChI:
InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1
InChIKey:
JKKFKPJIXZFSSB-CBZIJGRNSA-N
-
Cite this record
CBID:4142 http://www.chembase.cn/molecule-4142.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
|
[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
|
Synonyms
|
Estrone sulfate
|
Estropipate (usp)
|
OGEN
|
Ogen (TN)
|
Ogen 2.5
|
Estropipate
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEBI ID
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
-1.7480068
|
H Acceptors
|
4
|
H Donor
|
1
|
LogD (pH = 5.5)
|
1.4573227
|
LogD (pH = 7.4)
|
1.457317
|
Log P
|
3.8337157
|
Molar Refractivity
|
89.0742 cm3
|
Polarizability
|
35.487312 Å3
|
Polar Surface Area
|
80.67 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
Log P
|
0.29
|
LOG S
|
-4.77
|
Solubility (Water)
|
5.90e-03 g/l
|
PROPERTIES
PROPERTIES
Bioassay(PubChem)
DETAILS
DETAILS
DrugBank
Wikipedia
DrugBank -
DB04574
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Estropipate is a form of estrogen. It has several uses such as: Alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics,treatment of vaginal atrophy,treatment of some types of breast cancer (particularly in men and postmenopausal women), treatment of prostate cancer and prevention of osteoporosis.
|
Indication |
Estropipate is used for the treatment of moderate to severe vasomotor symptoms associated with the monopause, and moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. It is also used to treat hypoestrogenism due to hypogonadism, castration or primary ovarian failure, and prevent postmenopausal osteoporosis. |
Pharmacology |
Estropipate is an estrogenic substance. It acts as naturally produced estrogen does. Estrogens act through binding to nuclear receptors in estrogen-responsive tissues. Circulating estrogens modulate the pituitary secretion of the gonadotropins, luteinizing hormone (LH) and follicle stimulating hormone (FSH), through a negative feedback mechanism. Estrogens act to reduce the elevated levels of these hormones seen in postmenopausal women. |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Exogenous estrogens are metabolized in the same manner as endogenous estrogens. Circulating estrogens exist in a dynamic equilibrium of metabolic interconversions. These transformations take place mainly in the liver. Estradiol is converted reversibly to estrone, and both can be converted to estriol, which is the major urinary metabolite. Estrogens also undergo enterohepatic recirculation via sulfate and glucuronide conjugation in the liver, biliary secretion of conjugates into the intestine, and hydrolysis in the gut followed by reabsorption. In postmenopausal women, a significant proportion of the circulating estrogens exist as sulfate conjugates, especially estrone sulfate, which serves as a circulating reservoir for the formation of more active estrogens. |
Absorption |
Estropipate is well absorbed through the skin and gastrointestinal tract. When applied for a local action, absorption is usually sufficient to cause systemic effects. |
Elimination |
Estradiol, estrone and estriol are excreted in the urine along with glucuronide and sulfate conjugates |
External Links |
|
|
PATENTS
PATENTS
PubChem Patent
Google Patent